CapForce (OPGN) Q4 2025 earnings summary

Executive summary

• Completed strategic repositioning from precision medicine to financial technology and capital markets advisory, including the acquisition of iCapX and launch of digital investment banking services.

• Achieved significant revenue growth in 2025, driven by listing sponsorship services and related advisory contracts, with legacy operations scaled down.

• AEI Capital Ltd. became controlling shareholder, providing ongoing financial support and strategic direction.

• Company now operates virtually in the U.S. and from Malaysia, focusing on Asia-Pacific capital markets.

Financial highlights

• Total revenue for 2025 was $30.2 million, up from $5.2 million in 2024, primarily from listing sponsorship services.

• Net income for 2025 was $23.6 million, compared to $12.0 million in 2024.

• Operating expenses increased to $6.2 million in 2025 from $4.9 million in 2024, mainly due to higher service costs.

• Cash and cash equivalents at year-end 2025 were $0.5 million, with access to an additional $6.5 million in equity financing from AEI Capital Ltd.

• Investment in equity securities valued at $35.0 million as of December 31, 2025, received as consideration for advisory services.

Outlook and guidance

• Plans to fund operations primarily through AEI Capital Ltd. until business operations are self-sustaining.

• Focus on expanding digital investment banking, cross-border trading, and fintech-enabled services in Asia-Pacific.

• Anticipates continued revenue growth from advisory and platform services, with a pipeline of new business opportunities.